Range
16.35 - 17.39
Vol / Avg.
0.3K/0.9K
Div / Yield
-
52 Wk
2.13 - 17.39
Mkt Cap
850.6M
Payout Ratio
-
Open
16.35
P/E
-
EPS
-0.51
Shares
48.9M
Outstanding
-
Total Float
-
Advanz Pharma Corp Ltd is an international specialty pharmaceutical company, owning or licensing, through its subsidiaries, a diversified portfolio of branded and generic prescription products. The company has two reportable segments, which consist of ADVANZ PHARMA International and ADVANZ PHARMA North America. In ADVANZ PHARMA North America segment revenue is derived from two customer groups, which include wholesalers and authorized generic partners. In ADVANZ PHARMA International segment revenue is recognized at the time of sale to the wholesalers, hospitals, and pharmacies.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CXRXFAdvanz Pharma1.7%850.6M

Advanz Pharma Company Questions & Answers

Q

How do I buy Advanz Pharma (CXRXF) stock?

A

You can purchase shares of Advanz Pharma (OTC: CXRXF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Advanz Pharma's (CXRXF) main competitors?

A

There are no as such competitors for Advanz Pharma.

Q

What is the target price for Advanz Pharma?

A

The latest price target for Advanz Pharma (OTC: CXRXF) was reported by TD Securities on 2017-02-08. The analyst firm set a price target for 1.00 expecting CXRXF to fall to within 12 months (a possible -94.25% downside). 0 analyst firms have reported ratings in the last year.

Q

How much is Advanz Pharma (CXRXF) stock ?

A

The stock price for Advanz Pharma (OTC: CXRXF) is $17.39 last updated Fri May 14 2021 19:53:07 GMT+0000 (Coordinated Universal Time).

Q

When is the next Advanz Pharma (CXRXF) dividend?

A

There are no upcoming dividends for Advanz Pharma.

Q

When is Advanz Pharma (OTC:CXRXF) reporting earnings?

A

There are no earnings for Advanz Pharma

Q

When is the upcoming split for CXRXF?

A

There is no upcoming split for Advanz Pharma.